Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
M1774 + Cemiplimab for Advanced Lung Cancer
Recruiting1 awardPhase 1 & 2
Santa Monica, California
This trial tests a new drug to treat advanced NSCLC after other treatments have failed. It will measure effectiveness, safety, and how the body absorbs the drug.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service